Anthony Lucci

Anthony Lucci

UNVERIFIED PROFILE

Are you Anthony Lucci?   Register this Author

Register author
Anthony Lucci

Anthony Lucci

Publications by authors named "Anthony Lucci"

Are you Anthony Lucci?   Register this Author

100Publications

2584Reads

30Profile Views

Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.

Pract Radiat Oncol 2019 Nov 24;9(6):402-409. Epub 2019 May 24.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prro.2019.05.011DOI Listing
November 2019

Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.

J Surg Res 2019 Nov 3;243:90-99. Epub 2019 Jun 3.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2019.04.090DOI Listing
November 2019

Circulating Tumor Cells in Breast Cancer.

Recent Results Cancer Res 2020 ;215:127-145

M. D. Anderson Cancer Center, University of Texas, 1400 Pressler Street, FCT7.6000, Unit 1484, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-26439-0_7DOI Listing
October 2019

The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.

J Transl Med 2019 Sep 23;17(1):318. Epub 2019 Sep 23.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, South Campus Research Building 4, 1901 East Road, Houston, TX, 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-019-2069-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757394PMC
September 2019

Nipple sparing mastectomy for melanoma metastatic to the breast.

Breast J 2019 07 9;25(4):741. Epub 2019 May 9.

Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13322DOI Listing
July 2019

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential.

Oncotarget 2019 Jun 4;10(38):3681-3693. Epub 2019 Jun 4.

Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26978DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557209PMC
June 2019

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.

Cancers (Basel) 2019 Jun 20;11(6). Epub 2019 Jun 20.

Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11060856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628316PMC
June 2019

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.

J Cancer 2019 2;10(12):2635-2642. Epub 2019 Jun 2.

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.32453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584927PMC
June 2019

Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.

Surg Clin North Am 2018 Aug 24;98(4):787-800. Epub 2018 May 24.

Morgan Welch Inflammatory Breast Cancer Research and Clinic Program, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suc.2018.03.009DOI Listing
August 2018

Circulating Tumor Cells in Stage IV Melanoma Patients.

J Am Coll Surg 2018 07 7;227(1):116-124. Epub 2018 May 7.

Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2018.04.026DOI Listing
July 2018

Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.

Clin Breast Cancer 2018 02 10;18(1):e73-e77. Epub 2017 Jul 10.

Department of Breast Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.06.014DOI Listing
February 2018

Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.

Ann Surg Oncol 2018 Feb 20;25(2):512-519. Epub 2017 Nov 20.

Division of Surgery, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-6254-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790421PMC
February 2018

A usable model of "decathlon winner" cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence.

Oncotarget 2018 Feb 25;9(13):11071-11082. Epub 2018 Jan 25.

Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834289PMC
February 2018

Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.

J Surg Oncol 2017 Dec 22;116(8):1016-1020. Epub 2017 Aug 22.

The Christ Hospital Surgical Oncology Associates, Cincinnati, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24754DOI Listing
December 2017

Circulating Tumor Cells in Breast Cancer Patients.

Crit Rev Oncog 2016 ;21(1-2):125-39

The University of Texas M.D. Anderson Cancer Center, Department of Surgical Oncology, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1615/CritRevOncog.2016016120DOI Listing
October 2017

In response to "outcomes of patients with inflammatory breast cancer treated by breast conserving surgery": the argument against breast conservation and sentinel lymph node biopsy in IBC.

Breast Cancer Res Treat 2017 10 3;165(3):779-781. Epub 2017 Jul 3.

Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4337-y
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4337-yDOI Listing
October 2017

Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer.

Am J Surg 2017 Oct 23;214(4):666-671. Epub 2017 Jun 23.

Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2017.06.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770232PMC
October 2017

Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery.

Ann Surg Oncol 2017 Oct 1;24(10):2981-2988. Epub 2017 Aug 1.

Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, 1400 Pressler Drive, Unit 1434, FCT 7.5046, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5952-xDOI Listing
October 2017

Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge.

PLoS One 2016 8;11(7):e0159072. Epub 2016 Jul 8.

Department of Breast Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159072PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938613PMC
August 2017

Identification of frequent somatic mutations in inflammatory breast cancer.

Breast Cancer Res Treat 2017 Jun 27;163(2):263-272. Epub 2017 Feb 27.

Section of Translational Breast Cancer Research, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4165-0DOI Listing
June 2017

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

Lancet Oncol 2017 04;18(4):e228-e232

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30192-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140765PMC
April 2017

Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome.

Breast J 2010 Sep-Oct;16(5):529-32. Epub 2010 Jul 6.

Department of Breast Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas; Deparment of Medical Oncology, Dubai Hospital, Dubai, UAE.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1524-4741.2010.00953.x
Publisher Site
http://dx.doi.org/10.1111/j.1524-4741.2010.00953.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097300PMC
December 2016

Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients.

J Am Coll Surg 2016 07 8;223(1):20-9. Epub 2016 Mar 8.

The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jamcollsurg.2016.02.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868486PMC
July 2016

Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein.

J Clin Oncol 2016 05 21;34(15):1741-7. Epub 2016 Mar 21.

Shenying Fang, Dawen Sui, Yuling Wang, Huey Liu, Yi-Ju Chiang, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Jennifer Wargo, Mimi I. Hu, Julie M. Gardner, Roland L. Bassett, and Jeffrey E. Lee, The University of Texas MD Anderson Cancer Center; John D. Reveille, The University of Texas Health Science Center at Houston, Houston, TX; Qingyi Wei, Duke University School of Medicine, Durham, NC; and Christopher I. Amos, Dartmouth College, Lebanon, NH

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.1357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966337PMC
May 2016

Epidemiological risk factors associated with inflammatory breast cancer subtypes.

Cancer Causes Control 2016 Mar 21;27(3):359-66. Epub 2016 Jan 21.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, 1155 Pressler St., Unit 1360, P.O. Box 301439, Houston, TX, 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-015-0712-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778706PMC
March 2016

Highly adaptable triple-negative breast cancer cells as a functional model for testing anticancer agents.

PLoS One 2014 3;9(10):e109487. Epub 2014 Oct 3.

Department of Surgical Oncology, and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0109487PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184880PMC
January 2016

Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer.

Ann Surg Oncol 2015 Dec 13;22 Suppl 3:S552-8. Epub 2015 May 13.

Department of Surgical Oncology, Unit 444, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4600-6DOI Listing
December 2015

Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer.

J Natl Cancer Inst 2015 Nov 14;107(11). Epub 2015 Sep 14.

Departments of Surgical Oncology (CSH, MK, BAL, HMK, SD, AEA, AL), Surgical Pathology (SK), Breast Medical Oncology (VV, NTU), and Biostatistics (LY, SX), The University of Texas MD Anderson Cancer Center, Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849361PMC
November 2015

Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes.

J Invest Dermatol 2015 Sep 7;135(9):2266-2272. Epub 2015 Apr 7.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; These authors contributed equally to this work.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2015.138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580731PMC
September 2015

Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.

Melanoma Res 2015 Aug;25(4):335-41

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642955PMC
August 2015

Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.

Am J Clin Oncol 2015 Jun;38(3):242-7

Departments of *Radiation Oncology †Breast Medical Oncology §Surgical Oncology ∥Pathology ¶Diagnostic Radiology ‡Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3182937921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880388PMC
June 2015

C-reactive protein as a marker of melanoma progression.

J Clin Oncol 2015 Apr 16;33(12):1389-96. Epub 2015 Mar 16.

Shenying Fang, Yuling Wang, Dawen Sui, Huey Liu, Merrick I. Ross, Jeffrey E. Gershenwald, Janice N. Cormier, Richard E. Royal, Anthony Lucci, Christopher W. Schacherer, Julie M. Gardner, Roland L. Bassett, Li-E Wang, and Jeffrey E. Lee, University of Texas MD Anderson Cancer Center; John D. Reveille, University of Texas Health Science Center at Houston, Houston, TX; Qingyi Wei, Duke University School of Medicine, Durham, NC; and Christopher I. Amos, Geisel College of Medicine, Dartmouth College, Lebanon, NH.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/03/16/JCO.2014.58
Web Search
http://dx.doi.org/10.1200/JCO.2014.58.0209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397281PMC
April 2015

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.

J Natl Cancer Inst 2014 Dec 7;106(12). Epub 2014 Nov 7.

Department of Surgery and GROW School for Oncology and Developmental Biology (MM, MLS), Department of Surgery and Radiology (LMvR), Department of Medical Oncology, GROW School for Oncology and Developmental Biology (VCGTH), and Department of Epidemiology and GROW School for Oncology and Developmental Biology (ACV), Maastricht University Medical Center, Maastricht, the Netherlands; Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (LJAS); Division of Medical Oncology, Luzerner Kantonsspital, Lucerne, Switzerland (SA); Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian (DAC), Edinburgh Breast Unit (JMD), Western General Hospital, Edinburgh, UK; Cedars-Sinai Medical Center, Los Angeles, CA (AEG); Rutgers Cancer Institute of New Jersey, New Brunswick, NJ (BGH); Mater Centre Radiation Oncology Service, Princess Alexandra Hospital, Brisbane, Australia (BEH); Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center and Professor of Medicine, Weill Cornell Medical College, New York, NY (CAH); University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR (VSK); Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, Australia (BK); Interdisciplinary Breast Centre, Department of Gynaecology and Obstetrics, Klinikum Esslingen, Germany (TK); University of Miami Miller School of Medicine, Miami, FL (MEL); Radiation Oncology (BDS) and Department of Surgical Oncology, Division of Surgery (AL), University of Texas/MD Anderson Cancer Center, Houston, TX; Institut Jules Bordet, Université Libre de Bruxelles, Head of Medicine Department, Brussels, Belgium (MP); Surgery, University Medical Center, Leiden, the Netherlands (CJHvdV); Breast Service, Memorial Sloan-Kettering Cancer Center, Evelyn Lauder Breast Center, New York, NY(KJVZ); Antwerp University Hospital, Department of Medical Oncology, Edegem, Belgium (JBV); Department of Pathology, European Institute of

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357796PMC
December 2014

Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis.

Cancer Cell 2014 Nov 23;26(5):707-21. Epub 2014 Oct 23.

Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Matrix Biology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2014.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254633PMC
November 2014

Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients.

Mol Clin Oncol 2014 Sep 23;2(5):845-850. Epub 2014 Jun 23.

Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mco.2014.327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106732PMC
September 2014

Circulating tumor cells in non-metastatic triple-negative breast cancer.

Breast Cancer Res Treat 2014 Sep 28;147(2):325-33. Epub 2014 Aug 28.

Department of Surgical Oncology, Unit 0444, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-014-3103-7
Publisher Site
http://dx.doi.org/10.1007/s10549-014-3103-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149877PMC
September 2014

Inflammatory breast cancer: what we know and what we need to learn.

Oncologist 2012 14;17(7):891-9. Epub 2012 May 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399643PMC
February 2013

Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone.

Plast Reconstr Surg 2012 Dec;130(6):1169-78

Department of Plastic Surgery and the Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0b013e31826d0faaDOI Listing
December 2012

Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons.

Ann Surg Oncol 2012 Oct 21;19(10):3152-8. Epub 2012 Jul 21.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.springerlink.com/index/W144V48LW461QL67.pdf
Web Search
http://www.springerlink.com/index/10.1245/s10434-012-2523-z
Publisher Site
http://dx.doi.org/10.1245/s10434-012-2523-zDOI Listing
October 2012

Invasive lobular carcinoma predicts micrometastasis in breast cancer.

J Surg Res 2012 Sep 28;177(1):93-6. Epub 2012 Mar 28.

Department of Surgical Oncology, The University of Texas, MD, Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2012.03.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419792PMC
September 2012

Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.

Int J Radiat Oncol Biol Phys 2012 Aug 26;83(5):1381-6. Epub 2012 Jan 26.

Department of Radiation Oncology, The Morgan Welch Inflammatory Breast Cancer Clinic, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.10.040DOI Listing
August 2012

Circulating tumour cells in non-metastatic breast cancer: a prospective study.

Lancet Oncol 2012 Jul 6;13(7):688-95. Epub 2012 Jun 6.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70209-7DOI Listing
July 2012

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.

Breast Cancer Res Treat 2012 Jun 4;133(3):1131-41. Epub 2012 Mar 4.

Department of Surgical Oncology, DCIS Discovery Enterprise, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-1999-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855009PMC
June 2012

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.

J Clin Oncol 2012 Feb 17;30(6):600-7. Epub 2012 Jan 17.

Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.4976DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295558PMC
February 2012

Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer.

Cancer 2012 Jan 29;118(2):342-8. Epub 2011 Jun 29.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26202DOI Listing
January 2012

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.

Cancer 2011 Dec 28;117(24):5476-84. Epub 2011 Jun 28.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.26179
Publisher Site
http://dx.doi.org/10.1002/cncr.26179DOI Listing
December 2011

Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.

Ann Surg Oncol 2011 Oct 8;18(10):2873-8. Epub 2011 Apr 8.

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-1707-2DOI Listing
October 2011

Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy.

Plast Reconstr Surg 2011 May;127(5):1763-72

Department of Surgical Oncology, Plastic Surgery, Radiation Oncology, and Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0b013e31820cf24cDOI Listing
May 2011

Oncoplastics: techniques for reconstruction of partial breast defects based on tumor location.

J Surg Oncol 2011 Mar;103(4):341-7

Department of Surgical Oncology, The Methodist Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21672DOI Listing
March 2011

How heterogeneous cell populations, cancer cell dormancy, and minimal residual disease influence the natural history of cancers.

Oncology (Williston Park) 2011 Jan;25(1):47, 50

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
January 2011

Inflammatory breast cancer: the disease, the biology, the treatment.

CA Cancer J Clin 2010 Nov-Dec;60(6):351-75. Epub 2010 Oct 19.

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.20082DOI Listing
December 2010

Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines.

J Surg Res 2010 Oct 26;163(2):235-43. Epub 2010 May 26.

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2010.04.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943002PMC
October 2010

Does blue dye contribute to success of sentinel node mapping for breast cancer?

Ann Surg Oncol 2010 Oct 19;17 Suppl 3:280-5. Epub 2010 Sep 19.

Department of Surgical Oncology, M. D. Anderson Cancer Center, The University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-1235-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341979PMC
October 2010

The suture scaffold technique for improved cosmesis in partial mastectomy defects.

J Surg Oncol 2010 Aug;102(2):184-6

Department of Surgery, The Methodist Hospital, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21587DOI Listing
August 2010